COVID-19 Report for Life Sciences and Health Care Companies - December 2021

Hogan Lovells

Hogan Lovells

The COVID-19 Report is a compilation of coronavirus news, analysis, and insights from around the world to help life sciences and health care companies stay current in this challenging time.

In this week's Report: FDA issues response to omicron variant and funds project to expand ARGOS bioinformatics database; and an analysis of U.S. antitrust enforcement trends in labor markets.

Wednesday, 1 December 2021

  • Yesterday, the U.S. Food and Drug Administration issued a statement that it is actively working with federal partners, international regulators, and medical product companies to quickly address any potential impacts of the new omicron variant on the tools to fight the pandemic. And in a new project funded by the FDA, Embleema and George Washington University will conduct bioinformatic research and system development to expand the FDA-ARGOS database. FDA-ARGOS contains curated, quality-controlled genomic sequence data to support research and regulatory decisions. For example, researchers can use the FDA-ARGOS along with bioinformatics tools to validate the performance, sensitivity and specificity of diagnostic tests with computer modeling. Building on expansions during the COVID-19 pandemic, this project aims to further improve the utility of the FDA-ARGOS database as a key tool for medical countermeasure development and validation. (Authored by Randy Prebula)

  • The COVID-19 pandemic has caused upheaval across labor markets and resulted in what some have termed the “Great Resignation.” In the midst of these challenging labor market conditions, employers should be aware that the Department of Justice Antitrust Division and Federal Trade Commission (FTC) in the U.S. continue to expand their scrutiny of agreements that restrict the solicitation, wages, or movement of employees. It is important to stay up to date on these developments and to understand what circumstances may separate common, lawful business practices from possible antitrust violations. Online here we have analyzed how U.S. antitrust enforcement actions in labor markets continue to evolve in response to the pandemic and other global trends. (Authored by Benjamin Holt)

Compiled by Aaron Armstrong

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Hogan Lovells | Attorney Advertising

Written by:

Hogan Lovells

Hogan Lovells on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.